Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Costco Wholesale Corporation (COST) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Costco Wholesale CorporationTrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Costco Wholesale Corporation vs IDEXX Laboratories, Inc. — how do they compare? Costco Wholesale Corporation trades at $924.91 (market cap $408.78B), while IDEXX Laboratories, Inc. trades at $564.35 (market cap $42.65B). The key difference: Costco Wholesale Corporation is far larger — about 9.6× IDEXX Laboratories, Inc.'s market cap, and Costco Wholesale Corporation pays a 0.64% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.

COSTIDXX
Market Cap
$408.78B$42.65B
Sector
Consumer StaplesHealth
52-Week High
$1.09K$766.68
52-Week Low
$849.63$514.61
Enterprise Value
$396.92B$43.56B
Dividend Yield
0.64%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Costco Wholesale Corporation

Costco (COST) trades at $923.9, down 0.27% with bearish technical signals but strong fundamentals. The stock shows consistent revenue growth, reaching $275.24B in 2025 with net income of $8.10B. Recent March sales surged 11.3% year-over-year to $28.41B, indicating robust business momentum. Analyst consensus remains strongly bullish with 65.5% buy ratings and a $1,120 price target, though valuation metrics appear elevated with P/E at 46.37.

The investment case balances premium valuation against exceptional operational execution. Membership fee increases and expanding warehouse network drive profitability, but high P/E ratio requires sustained growth. Key risks include competitive pressure and economic sensitivity, while institutional accumulation supports long-term confidence.

IDEXX Laboratories, Inc.

IDXX trades at $564.09, up 0.09% with neutral technical signals. The stock shows strong fundamentals with revenue growth to $4.3B in 2025 and consistent earnings beats. Analyst consensus is bullish (59% Buy) with improving cash flow trends. Recent news highlights AI integration in medical devices and upcoming Q2 2026 earnings.

Outlook remains positive driven by innovation and market leadership in pet healthcare. Risks include high valuation multiples and competitive pressures. Institutional sentiment supports growth, but investors should monitor execution against elevated expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Costco Wholesale Corporation

The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet

Read more on COST

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX